Jennison Associates’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-308,200
Closed -$34.6M 664
2015
Q3
$55M Buy
308,200
+2,364
+0.8% +$551K 0.06% 285
2015
Q2
$67.9M Buy
305,836
+3,022
+1% +$670K 0.06% 279
2015
Q1
$60.1M Buy
302,814
+951
+0.3% +$169K 0.06% 299
2014
Q4
$43.2M Sell
301,863
-326
-0.1% -$43.8K 0.04% 349
2014
Q3
$39.6M Sell
302,189
-86,517
-22% -$10.3M 0.04% 361
2014
Q2
$49M Buy
+388,706
New +$49.6M 0.05% 336
2014
Q1
Sell
-1,229,094
Closed -$144M 737
2013
Q4
$144M Sell
1,229,094
-190,666
-13% -$20.9M 0.14% 142
2013
Q3
$148M Sell
1,419,760
-15,541
-1% -$1.51M 0.16% 134
2013
Q2
$124M Buy
+1,435,301
New +$113M 0.14% 149

Other funds holding BHC

Jennison Associates's BHC Position: Q4 2015 in Review

Jennison Associates sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 308,200 shares — an estimated $34.6M sold.

Jennison Associates first reported a position in BHC in Q2 2013 and held it in 9 quarters. The position peaked at $148M in Q3 2013. 452 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Jennison Associates reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Jennison Associates sold 308,200 Bausch Health shares in Q4 2015, an estimated $34.6M.
  • Jennison Associates first reported a position in Bausch Health in Q2 2013 and held it in 9 quarters.
  • Jennison Associates's Bausch Health position peaked at $148M in Q3 2013.
  • 452 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Jennison Associates's 13F filing for Q4 2015, filed 10 Feb 2016.